FDA Issues Warning Letter to Sombra Cosmetics
December 24, 2024
December 24, 2024
WASHINGTON, Dec. 24 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Sombra Cosmetics Inc.:
* * *
To: Mr. Alfredo Cortazar, Owner and Chief Executive Officer (CEO), Sombra Cosmetics, Inc., 5951 Office Blvd NE, Albuquerque, NM 87109-5822, United States
Dear Mr. Cortazar:
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, Sombra Cosmetics, . . .
* * *
To: Mr. Alfredo Cortazar, Owner and Chief Executive Officer (CEO), Sombra Cosmetics, Inc., 5951 Office Blvd NE, Albuquerque, NM 87109-5822, United States
Dear Mr. Cortazar:
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, Sombra Cosmetics, . . .